510(k) · Cleared
ClearedModification to Cavermap Surgical Aid
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Blue Torch Medical Technologies · FGM Probe And Director, Gastro-Urology
Cleared on Jun 5, 2003 after a 21-day review. The summary cites one number, which could not be confirmed as its predicate (see the table below).
- Decided
- Jun 5, 2003
- Review
- 21 days
- Class
- Class I
- Product code
- FGM
- Recalls
- None
- Predicates
- 1
The summary cites one number, which could not be confirmed as its predicate (see the table below).
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in FGM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary; numbers the summary cites that cannot be its predicate are marked – and kept off the family tree.
| Type | Number | Device | Decided |
|---|---|---|---|
| Kept off the family tree | K970971 | FDA’s K970971 is Uro Med Nerve Stimulator Our reading of the summary gave K970971, FDA’s number for Uro Med Nerve Stimulator (Uromed Corp.). Its FDA name has none of the distinctive words the summary uses for the device it names, “Blue Torch Medical Technologies CaverMap Surgical Aid”. Kept off the family tree. Summary page 1…4730 Probe And Director, Gastro-Urology Predicate Devices used for Substantial Equivalence Blue Torch Medtcal Technologies CaverMap Surgcal A d K970971 Intended Use The Blue Torch Medical Technologies CaverMap Surgical Aid is intended to provide stimulation to the body to locate… | 1997 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
How does its category compare?
All FGM devicesFGM Probe And Director, Gastro-Urology: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · FGM
FDA has decided no FGM device since 2007.
Median 510(k) review, days · FGM
Too few FGM 510(k)s in any year since 2007 to give a median.
Recalls per year · FGM
No recall names FGM since 2007.
Adverse event reports per year · FGM
1in 2015
MAUDE reports naming product code FGM, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 1 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 2 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 1 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Blue Torch Medical Technologies CaverMapB Surgical Aid Video Monitor is a modification to the Blue Torch Medical Technologies CaverMapR Surgical Aid System. The system is indicated for use in the stimulation of the cavernosal and associated parasympathetic nerves during open or laproscopic prostatectomy and open colorectal (surgical) procedures in males. The device aids the surgeon in locating these nerves. The device is designed as an adjunct to the…
Read the full statement (116 words)
The Blue Torch Medical Technologies CaverMapB Surgical Aid Video Monitor is a modification to the Blue Torch Medical Technologies CaverMapR Surgical Aid System. The system is indicated for use in the stimulation of the cavernosal and associated parasympathetic nerves during open or laproscopic prostatectomy and open colorectal (surgical) procedures in males. The device aids the surgeon in locating these nerves. The device is designed as an adjunct to the current open or laproscopic prostatectomy and open colorectal procedures in which a nerve sparing technique is used. The Surgical Aid is not designed to replace the surgeon’s expertise in mapping out the neurovascular bundles. Each surgeon’s skill determines whether these nerves are spared regardless of any aid.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K031527 · printed Nov 6, 2026
Cite this page
510(k) Report. “K031527: Modification to Cavermap Surgical Aid.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K031527
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Page last updated Nov 3, 2026